@article {Cho15, author = {Leslie Cho}, title = {A practical approach to the cholesterol guidelines and ASCVD prevention}, volume = {87}, number = {5 suppl 1}, pages = {15--20}, year = {2020}, doi = {10.3949/ccjm.87.s1.02}, publisher = {Cleveland Clinic Journal of Medicine}, abstract = {Lifestyle factors remain the bedrock of atherosclerotic cardiovascular disease (ASCVD) prevention. Statins remain the first-line therapy for primary and secondary prevention of ASCVD. Physicians are encouraged to discuss the risks and benefits of statins with patients before beginning therapy. Nonstatins and proprotein convertase subtilisin-kexin type 9 inhibitors are recommended for secondary prevention in patients with clinical ASCVD. For patients at intermediate risk of ASCVD, new risk-enhancing factors, including chronic inflammatory conditions and ethnicity, should be considered to better risk stratify these patients.}, issn = {0891-1150}, URL = {https://www.ccjm.org/content/87/5_suppl_1/15}, eprint = {https://www.ccjm.org/content/87/5_suppl_1/15.full.pdf}, journal = {Cleveland Clinic Journal of Medicine} }